HomeVRPX • OTCMKTS
add
Virpax Pharmaceuticals Inc
Previous close
$0.021
Day range
$0.021 - $0.025
Year range
$0.010 - $3.77
Market cap
28.19K USD
Avg Volume
2.19K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.39M | -27.53% |
Net income | -3.39M | 25.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.51M | -83.45% |
Total assets | 1.56M | -83.84% |
Total liabilities | 2.47M | -67.91% |
Total equity | -913.76K | — |
Shares outstanding | 1.06M | — |
Price to book | -0.01 | — |
Return on assets | -912.67% | — |
Return on capital | 572.40% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.39M | 25.68% |
Cash from operations | -2.87M | 4.68% |
Cash from investing | — | — |
Cash from financing | 4.37M | — |
Net change in cash | 1.50M | 149.67% |
Free cash flow | -1.76M | -27.53% |
About
Founded
2016
Headquarters
Website
Employees
2
